GATA2 Transcription Factor
"GATA2 Transcription Factor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An essential GATA transcription factor that is expressed primarily in HEMATOPOIETIC STEM CELLS.
Descriptor ID |
D050989
|
MeSH Number(s) |
D12.776.260.235.625 D12.776.260.257.200 D12.776.930.216.625 D12.776.930.314.200
|
Concept/Terms |
GATA2 Transcription Factor- GATA2 Transcription Factor
- Transcription Factor, GATA2
- Transcription Factor GATA-2
- GATA-2, Transcription Factor
- Transcription Factor GATA 2
- NFE1B Erythroid Transcription Factor
- Nuclear Factor-Erythroid 1B
- Nuclear Factor Erythroid 1B
- GATA-Binding Protein 2
- GATA Binding Protein 2
|
Below are MeSH descriptors whose meaning is more general than "GATA2 Transcription Factor".
Below are MeSH descriptors whose meaning is more specific than "GATA2 Transcription Factor".
This graph shows the total number of publications written about "GATA2 Transcription Factor" by people in this website by year, and whether "GATA2 Transcription Factor" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1997 | 0 | 1 | 1 |
1999 | 0 | 1 | 1 |
2000 | 0 | 1 | 1 |
2003 | 0 | 1 | 1 |
2005 | 1 | 1 | 2 |
2006 | 1 | 0 | 1 |
2008 | 0 | 1 | 1 |
2009 | 2 | 0 | 2 |
2012 | 1 | 0 | 1 |
2013 | 1 | 1 | 2 |
2014 | 2 | 0 | 2 |
2016 | 2 | 1 | 3 |
2018 | 1 | 2 | 3 |
2021 | 1 | 1 | 2 |
2022 | 1 | 0 | 1 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "GATA2 Transcription Factor" by people in Profiles.
-
Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41. Blood Adv. 2023 10 24; 7(20):6092-6107.
-
Invasive mucorales sinusitis in a young patient with Emberger syndrome and newly diagnosed AML: A case report and literature review of invasive fungal infections in GATA2 deficiency. Mycoses. 2023 Dec; 66(12):1029-1034.
-
Therapeutic targeting of FUBP3 phase separation by GATA2-AS1 inhibits malate-aspartate shuttle and neuroblastoma progression via modulating SUZ12 activity. Oncogene. 2023 09; 42(36):2673-2687.
-
A GATA2-CDC6 axis modulates androgen receptor blockade-induced senescence in prostate cancer. J Exp Clin Cancer Res. 2023 Jul 29; 42(1):187.
-
A COP1-GATA2 axis suppresses AR signaling and prostate cancer. Proc Natl Acad Sci U S A. 2022 10 25; 119(43):e2205350119.
-
Association of unbalanced translocation der(1;7) with germline GATA2 mutations. Blood. 2021 12 09; 138(23):2441-2445.
-
Inhibition of GATA2 in prostate cancer by a clinically available small molecule. Endocr Relat Cancer. 2021 11 24; 29(1):15-31.
-
GATA2 Deficiency in a Pediatric Patient. J Allergy Clin Immunol Pract. 2019 Jul - Aug; 7(6):2021-2022.
-
Myeloid malignancies with somatic GATA2 mutations can be associated with an immunodeficiency phenotype. Leuk Lymphoma. 2019 08; 60(8):2025-2033.
-
SOX17 regulates uterine epithelial-stromal cross-talk acting via a distal enhancer upstream of Ihh. Nat Commun. 2018 10 24; 9(1):4421.